0001447028-20-000027.txt : 20200219
0001447028-20-000027.hdr.sgml : 20200219
20200219080332
ACCESSION NUMBER: 0001447028-20-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200217
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HASTINGS DAVID C
CENTRAL INDEX KEY: 0001237401
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 20627446
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
wf-form4_158211739512646.xml
FORM 4
X0306
4
2020-02-17
0
0001447028
Arbutus Biopharma Corp
ABUS
0001237401
HASTINGS DAVID C
C/O ARBUTUS BIOPHARMA CORPORATION
701 VETERANS CIRCLE
WARMINSTER
PA
18974
0
1
0
0
Chief Financial Officer
Stock Options
3.35
2020-02-17
4
A
0
100000
0
A
2030-02-17
Common Stock
100000.0
100000
D
The stock option will vest and become exercisable 1/48th each month over the four year period.
/s/ Dave Kille as attorney-in-fact for David C. Hastings
2020-02-19